Literature DB >> 2656288

The use of 5-fluorocytosine and ketoconazole in the culture of the erythrocytic stages of Plasmodium falciparum and some tumor cell lines.

E F Roth1, J C McKitrick, F Herz.   

Abstract

In vitro culture systems are often contaminated by bacteria and fungi. It is therefore often necessary to supplement culture media with agents such as penicillin/streptomycin, gentamycin or amphotericin B. The latter cannot be used in the in vitro culture of erythrocytic stages of P. falciparum, and thus anti-fungal agents have not been regularly used in this system. We describe the prophylactic use of 5-fluorocytosine (5-FC) and ketoconazole (KTZ) in tissue cultures at concentrations up to 300 and 10 micrograms/ml respectively which have no effect on the growth of P. falciparum (FCR-3 strain). A melanoma cell line (C32) and a line of uterine carcinoma (C41) were also unaffected by similar concentrations of 5-FC and KTZ. When dissolved in complete culture medium (RPMI 1640) with 10% human plasma, the minimum inhibitory concentration of 5-FC for a susceptible strain of Candida remained below 2 micrograms/ml. These experiments suggest that 5-FC (at 50 micrograms/ml) alone or in combination with KTZ (at 1 microgram/ml) is a useful addition to the armamentarium of antimicrobials available to the tissue culture biologist for a variety of cell culture systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656288     DOI: 10.1007/bf01952037

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  9 in total

1.  Plasmodium falciparum in culture: use of outdated erthrocytes and description of the candle jar method.

Authors:  J B Jensen; W Trager
Journal:  J Parasitol       Date:  1977-10       Impact factor: 1.276

2.  Chromosome analysis and alkaline phosphatase of C41, a cell line of human cervical origin distinct from HeLa.

Authors:  F Herz; O J Miller; D A Miller; N Auersperg; L G Koss
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

3.  Imidazole and polyene activity against chloroquine-resistant Plasmodium falciparum.

Authors:  M A Pfaller; D J Krogstad
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

4.  Activity of ketoconazole and its deacyl derivative against Plasmodium falciparum and Candida isolates.

Authors:  M A Pfaller; J J Segal; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

5.  Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo.

Authors:  W Raether; H Seidenath
Journal:  Z Parasitenkd       Date:  1984

6.  Elimination of yeast contamination from malaria cultures using 5-fluorocytosine.

Authors:  J O Osisanya; S Gould; D C Warhurst
Journal:  Ann Trop Med Parasitol       Date:  1980-10

7.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06

8.  Pyrimidine de novo synthesis during the life cycle of the intraerythrocytic stage of Plasmodium falciparum.

Authors:  A M Gero; G V Brown; W J O'Sullivan
Journal:  J Parasitol       Date:  1984-08       Impact factor: 1.276

9.  Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum.

Authors:  E F Roth; C Raventos-Suarez; A Rinaldi; R L Nagel
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

  9 in total
  1 in total

1.  In vitro activity of antifungal drugs against Plasmodium falciparum field isolates.

Authors:  Peter Pongratz; Florian Kurth; Ghyslain Mombo Ngoma; Arti Basra; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2011-07-07       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.